1. HBW Insight
  2. >>Health

Stada Blasts German Sleep Aid Reverse Switch

 
• By David Ridley

Stada criticizes German switch committee's recommendation to restrict access to first generation antihistamines with a sedative effect for over-65s. 

Elderly_Sleep_Problems
• Source: Shutterstock

Stada Arzneimittel AG has criticized a decision by the Germany's Expert Committee for Prescription (SVA) to restrict access to sedative antihistamines for elderly consumers.

At its recent meeting, the SVA by majority recommended the OTC-to-prescription reverse-switch of both diphenhydramine and doxylamine for the treatment...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Rx-to-OTC Switch

More from Health

Moberg Has US Ambitions For Novel Nail Fungus Treatment

 
• By Tom Gallen

Sweden's Moberg wants to introduce its onychomycosis treatment to the US but expects it will need to complete an additional study to win FDA approval.

Maternal Nutrition, Contraceptive Innovation Among Gates Foundation’s Latest Research Goals

 
• By Malcolm Spicer

“Women’s health continues to be ignored, underfunded, and sidelined. Too many women still die from preventable causes or live in poor health. That must change,” says Bill Gates.

New US FDA Chief Counsel More Familiar With Trump World Than Food and Drug Law

 
• By Sarah Karlin-Smith

Sean Keveney is largely unknown in the FDA law space, but likely is familiar and connected to the White House given his work on Trump’s antisemitism taskforce.